Sign in
An open label pilot study evaluating the safety, tolerance and efficacy of thioguanine (6-TG) as an alternate therapy in patients failing 6-mercaptopurine (6-MP)
Journal article   Peer reviewed

An open label pilot study evaluating the safety, tolerance and efficacy of thioguanine (6-TG) as an alternate therapy in patients failing 6-mercaptopurine (6-MP)

Maria Dubinsky, Philip Hassard, Lori Kam, Maria Abreu, Ernest Seidman, Stephan Targan and Eric Vasiliauskas
The American journal of gastroenterology, Vol.95(9), pp.2532-2532
2000

Metrics

4 Record Views

Details